Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Author index

Acta Physiologica 2008; Volume 194, Supplement 666
Belgian Society for Fundamental and Clinical Physiology and Pharmacology, Spring Meeting 2008
5/17/2008-5/17/2008
University of Liège, Liège, Belgium

  • A
  •  | 
  • B
  •  | 
  • C
  •  | 
  • D
  •  | 
  • E
  •  | 
  • F
  •  | 
  • G
  •  | 
  • H
  •  | 
  • I
  •  | 
  • J
  •  | 
  • K
  •  | 
  • L
  •  | 
  • M
  •  | 
  • N
  •  | 
  • O
  •  | 
  • P
  •  | 
  • Q
  •  | 
  • R
  •  | 
  • S
  •  | 
  • T
  •  | 
  • U
  •  | 
  • V
  •  | 
  • W
  •  | 
  • X
  •  | 
  • Y
  •  | 
  • Z
  • M
    Mahmoudabady M.- MODULATION OF ANGIOGENIC FACTORS AFTER STEM CELL THERAPY IN A MODEL OF CHRONIC MYOCARDIAL INFARCTION
    Massie A.- IN VIVO NEUROCHEMICAL AND NEUROPROTECTIVE EFFECTS OF CANDESARTAN IN THE 6-HYDROXYDOPAMINE RAT MODEL FOR PARKINSONS DISEASE.
     - CHANGES IN STRIATAL GLUTAMATE IN THE 6-OHDA HEMI-PARKINSON RAT MODEL MIGHT BE THE RESULT OF A COMPLEX INTERPLAY BETWEEN GLIAL AND VESICULAR GLUTAMATE TRANSPORTERS
    Mathieu M.- MODULATION OF ANGIOGENIC FACTORS AFTER STEM CELL THERAPY IN A MODEL OF CHRONIC MYOCARDIAL INFARCTION
    Mc Entee K.- MODULATION OF ANGIOGENIC FACTORS AFTER STEM CELL THERAPY IN A MODEL OF CHRONIC MYOCARDIAL INFARCTION
     - AFTERLOAD EXPRESSED AS LEFT VENTRICULAR WALL STRESS AND SYSTEMIC VASCULAR RESISTANCE IN HEALTHY HORSES DURING PHARMACOLOGICAL STRESS TESTING
    Mendes Da Costa A.- MODULATION OF ANGIOGENIC FACTORS AFTER STEM CELL THERAPY IN A MODEL OF CHRONIC MYOCARDIAL INFARCTION
    Mertens B.- CHANGES IN STRIATAL GLUTAMATE IN THE 6-OHDA HEMI-PARKINSON RAT MODEL MIGHT BE THE RESULT OF A COMPLEX INTERPLAY BETWEEN GLIAL AND VESICULAR GLUTAMATE TRANSPORTERS
     - IN VIVO NEUROCHEMICAL AND NEUROPROTECTIVE EFFECTS OF CANDESARTAN IN THE 6-HYDROXYDOPAMINE RAT MODEL FOR PARKINSONS DISEASE.
    Meurs A.- SELECTIVE Y1 RECEPTOR ANTAGONISTS MAY NOT BE USEFUL IN THE TREATMENT OF LIMBIC SEIZURES
    Michotte Y.- SELECTIVE Y1 RECEPTOR ANTAGONISTS MAY NOT BE USEFUL IN THE TREATMENT OF LIMBIC SEIZURES
     - CHANGES IN STRIATAL GLUTAMATE IN THE 6-OHDA HEMI-PARKINSON RAT MODEL MIGHT BE THE RESULT OF A COMPLEX INTERPLAY BETWEEN GLIAL AND VESICULAR GLUTAMATE TRANSPORTERS
     - IN VIVO NEUROCHEMICAL AND NEUROPROTECTIVE EFFECTS OF CANDESARTAN IN THE 6-HYDROXYDOPAMINE RAT MODEL FOR PARKINSONS DISEASE.
    Multon S.- A BIPHASIC WAVEFORM FOR INDUCTION OF CORTICAL SPREADING DEPRESSION

     

    Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

    By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

    CLOSE